By Gabriel De Prado

Top Takeaways:

• Narrow authorization: FDA’s modified-risk order covers 20 specific ZYN products and one authorized claim, not the broader category.
• Retail responsibility: De Prado argues retailers must communicate exactly what FDA authorized without expanding or overstating the claim.
• Adult access: The authorization does not change retailers’ responsibility to restrict nicotine products to adults 21 and older.

After more than two decades in the tobacco and nicotine industry, I have seen first-hand that most adult tobacco and nicotine consumers don’t spend their time trying to make sense of regulatory language. They simply want access to clear, trustworthy information about nicotine alternatives before deciding whether to move away from cigarettes.

That’s why the U.S. Food and Drug Administration’s recent decision to allow specific nicotine pouch products to carry a modified-risk order, which allows the manufacturer to legally market specific products using government-authorized health claims, deserves not only attention but a complete understanding of this milestone moment for the category.

On June 30, 2026, the FDA authorized 20 ZYN nicotine pouch products to carry a specific claim: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”

The decision is a first for the nicotine pouch category. But the order is deliberately narrow, and its limits matter just as much as the claim itself.

The authorization followed more than a year of scientific review, including consideration of the products’ health risks, whether consumers understand the claim, potential youth impacts, and broader population-level effects. The process also included a public comment period and a public meeting of the agency’s scientific advisory committee.

As president of Haypp Group U.S., which operates Nicokick.com and Northerner.com—independent online retailers that source products directly from manufacturers—I believe we have a responsibility to explain what the decision means and what it does not. The order applies only to the specific ZYN products authorized: 10 flavors in 3 mg and 6 mg strengths. It does not cover ZYN as a brand, ZYN’s other strengths, or the other brands sold on our platforms.

The order also does not mean the covered products are safe or risk-free, and it is not a green light to use nicotine generally. The FDA said so directly. Nicotine is addictive, and these products are intended only for adults 21 and older who already use tobacco or nicotine.

What the order does provide is FDA-authorized information about specific products that adult consumers can consider when making their own choices. Our role is narrow: present the manufacturer’s claim exactly as authorized by the FDA, without stretching it into something it is not.

That discipline matters because nicotine pouches are still a relatively new part of the market. Although they have become popular among adults, confusion remains about how they are regulated and what FDA authorization means. We see it in the questions consumers ask online: Is this FDA approved? Is it the same as quitting? Does it apply to all nicotine pouches? The answers are no, no, and no.

Every retailer in this category has a responsibility to communicate those distinctions accurately. The greater risk is not saying too little. It is implying more than the agency authorized.

Nothing about this order changes whom we sell to or the safeguards governing those sales. Every order placed on Nicokick.com and Northerner.com undergoes identity verification to confirm that the buyer is 21 or older and is checked against the delivery address before anything ships. We built that system years before this claim existed, and it will not be relaxed now that different language is available.

Adult-only access must remain non-negotiable. This decision gives the industry more to communicate, but it also gives us more to prove.

Scrutiny is essential if online retail is to earn and retain public trust. Categories tend to lose that trust gradually, not all at once, but through a steady accumulation of overstated or poorly framed claims. Continued oversight helps ensure that claims remain grounded in scientific evidence and that retailers are held to meaningful adult-access standards.

The FDA did not hand the industry a blank check on June 30. It authorized 20 products to carry one specific sentence, subject to conditions that allow the agency to revisit the decision if the evidence or marketplace changes. That is exactly how the system should work.

More than 25 million American adults still smoke, and it remains the leading cause of preventable death in the U.S. They deserve accurate information about their options, drawn from rigorous scientific review rather than guesswork, and a marketplace grounded in verified information.

The worst thing we can do as a category is create a free-for-all. Our consumers deserve factual information, and that is the core of our operations and our commitment to the public.

Gabriel De Prado is president of Haypp Group U.S., which operates Nicokick.com and Northerner.com.